Cost-Effectiveness and Public Health Impact of Universal Prophylaxis with Nirsevimab Against Respiratory Syncytial Virus (RSV) Infections in all Infants in Japan by Shinichi Noto, Alexia Kieffer, Samira Soudani, Takeshi Arashiro, Chiho Tadera, Sebastien Eymere, Tobiasz Lemański, Xinyu Wang

Get full text

Sentinel Surveillance of COVID-19: The Importance of Epidemiologic Concepts and Reasoning by Yuzo Arima, Takuri Takahashi, Ayu Kasamatsu, Takeshi Arashiro, Yusuke Kobayashi, Miyako Otsuka, Osamu Takahara, Reiko Shimbashi, Katsuhiro Komase, Taro Kamigaki, Motoi Suzuki

Get full text

Serum anti-nucleocapsid antibody correlates of protection from SARS-CoV-2 re-infection regardless of symptoms or immune history by Sho Miyamoto, Koki Numakura, Ryo Kinoshita, Takeshi Arashiro, Hiromizu Takahashi, Hiromi Hibino, Minako Hayakawa, Takayuki Kanno, Akiko Sataka, Rena Sakamoto, Akira Ainai, Satoru Arai, Motoi Suzuki, Daisuke Yoneoka, Takaji Wakita, Tadaki Suzuki

Get full text

Prospective hospital-based cohort studies of Respiratory Syncytial Virus (RSV) infections in infants under one year during and after the SARS-CoV-2 pandemic in Japan by Koo Nagasawa, Mihoko Ohata, Ataru Igarashi, Takeshi Arashiro, Tomoko Ogawa, Misako Ohkusu, Noriko Takeuchi, Kenichi Shizuno, Erika Kurihara, Misato Yoshida, Takahiro Kodama, Katsuaki Abe, Tadashi Hoshino, Junko Arii, Kenichi Takeshita, Haruka Hishiki, Setsuo Ota, Yoshiko Takahashi, Yuko Omata, Tomoko Nakazawa, Tomohiro Someya, Naruhiko Ishiwada

Get full text